Statistics

Total Visits

Views
Faldaprevir Plus Pegylated Interferon Alfa-2a and Ribavirin in Chronic HCV Genotype-1 Treatment-Naive Patients: Final Results from STARTVerso1: A Randomized, Double-blind, Placebo-Controlled, Phase 3 Trial98

Select a period of time:

Number of views in the range

Views
Faldaprevir Plus Pegylated Interferon Alfa-2a and Ribavirin in Chronic HCV Genotype-1 Treatment-Naive Patients: Final Results from STARTVerso1: A Randomized, Double-blind, Placebo-Controlled, Phase 3 Trial18

Views

Views
October 20251
November 20252
December 20252
January 20266
February 20260
March 20266
April 20261
Download CSV file
 untranslated
 untranslated

Top country views

Views
Finland4
United Kingdom3
Canada2
United States2
Bolivia2
Argentina1
Brazil1
Switzerland1
Chile1
Ecuador1
 

Top cities views

Views
Helsinki4
Ottawa2
Cochabamba1
Curitiba1
La Paz1
Rancagua1
San Juan1
Santa Clara1
Santo Domingo de los Colorados1
Zurich1